UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2013, Volume 309, Issue 12, pp. 1251 - 1259
LOW-DOSE AZITHROMYCIN | LONG-TERM AZITHROMYCIN | PSEUDOMONAS-AERUGINOSA | DOUBLE-BLIND | GEORGES RESPIRATORY QUESTIONNAIRE | STAPHYLOCOCCUS-AUREUS | PULMONARY-FUNCTION | PLACEBO-CONTROLLED TRIAL | MACROLIDE RESISTANCE | HEALTH-STATUS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Errors of metabolism | General aspects | Respiratory system : syndromes and miscellaneous diseases | Biological and medical sciences | Metabolic diseases | Medical sciences | Miscellaneous hereditary metabolic disorders | Pneumology | Sputum - microbiology | Double-Blind Method | Bacterial Infections - etiology | Humans | Middle Aged | Respiratory Tract Infections - prevention & control | Drug Resistance, Bacterial | Male | Inflammation | Lung - physiopathology | Biomarkers - blood | Anti-Bacterial Agents - therapeutic use | Azithromycin - adverse effects | Bacterial Infections - prevention & control | Bronchiectasis - complications | Azithromycin - therapeutic use | Quality of Life | Adult | Female | Respiratory Tract Infections - etiology | Aged | Anti-Bacterial Agents - adverse effects | Respiratory Function Tests | Clinical trials | Cystic fibrosis | Antibiotics | Medical treatment | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 09/2013, Volume 70, Issue 9, pp. 913 - 920
PLACEBO | ANTIPSYCHOTICS | PREDICTORS | DOUBLE-BLIND | SCHIZOAFFECTIVE DISORDER | SCHIZOPHRENIA | 1ST EPISODE PSYCHOSIS | DISCONTINUATION | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Biological and medical sciences | Psychology. Psychoanalysis. Psychiatry | Medical sciences | Psychopathology. Psychiatry | Recurrence | Follow-Up Studies | Humans | Male | Treatment Outcome | Long-Term Care | Remission Induction | Antipsychotic Agents - administration & dosage | Young Adult | Maintenance Chemotherapy - methods | Age of Onset | Adult | Female | Psychotic Disorders - drug therapy | Antipsychotic Agents - pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
2013, Essays in cognitive psychology, ISBN 1848726503, xvii, 310
Book
Inflammatory bowel diseases, ISSN 1078-0998, 09/2009, Volume 15, Issue 9, pp. 1295 - 1301
changing disease course | Crohn's disease | long‐term endoscopic outcome | infliximab | mucosal healing | Long-term endoscopic outcome | Mucosal healing | Infliximab | Changing disease course | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Prognosis | Follow-Up Studies | Humans | Endoscopy, Gastrointestinal | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Young Adult | Time Factors | Crohn Disease - drug therapy | Adolescent | Gastrointestinal Agents - therapeutic use | Adult | Female | Mucous Membrane - drug effects | Wound Healing - drug effects | Cohort Studies | Index Medicus
Journal Article
Health psychology, ISSN 0278-6133, 1/2000, Volume 19, Issue 1S, pp. 5 - 16
Obesity | Treatment | Maintenance review | Psychology, Clinical | Psychology | Social Sciences | Behavior Therapy | Cardiovascular Diseases - etiology | Life Style | Follow-Up Studies | Obesity - psychology | Cardiovascular Diseases - prevention & control | Humans | Male | Long-Term Care | Health Knowledge, Attitudes, Practice | Weight Loss | Adolescent | Obesity - therapy | Adult | Female | Child | Management | Reducing diets | Analysis | Weight loss | Index Medicus
Journal Article
Inflammatory bowel diseases, ISSN 1078-0998, 02/2012, Volume 18, Issue 2, pp. 201 - 211
long‐term maintenance therapy | ulcerative colitis | ACT extension study | infliximab | long-term maintenance therapy | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Male | Treatment Outcome | Colectomy | Infliximab | Antibodies, Monoclonal - administration & dosage | Treatment Refusal | Adult | Colitis, Ulcerative - surgery | Female | Surveys and Questionnaires | Gastrointestinal Agents - adverse effects | Colitis, Ulcerative - drug therapy | Index Medicus
Journal Article
Journal of addictive diseases, ISSN 1055-0887, 07/2012, Volume 31, Issue 3, pp. 207 - 225
naltrexone | buprenorphine | pharmacotherapy | addiction | Review | methadone | opiate | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Naltrexone - therapeutic use | Opioid-Related Disorders - drug therapy | Humans | Methadone - therapeutic use | Analgesics, Opioid - pharmacology | Substance Withdrawal Syndrome - drug therapy | Analgesics, Opioid - therapeutic use | Buprenorphine - pharmacokinetics | Treatment Outcome | Long-Term Care | Buprenorphine - pharmacology | Opioid-Related Disorders - epidemiology | Opioid-Related Disorders - rehabilitation | Naltrexone - pharmacology | Buprenorphine - therapeutic use | Naltrexone - pharmacokinetics | Narcotic Antagonists - therapeutic use | Narcotic Antagonists - pharmacology | Analgesics, Opioid - pharmacokinetics | Opiate Substitution Treatment | Narcotic Antagonists - pharmacokinetics | Methadone - pharmacokinetics | Methadone - pharmacology | Intervention | Drug addiction | Substance abuse treatment | Mortality | Morbidity | Index Medicus
Journal Article
8.
Full Text
Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
Gut, ISSN 0017-5749, 09/2007, Volume 56, Issue 9, pp. 1232 - 1239
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Male | Treatment Outcome | Crohn Disease - immunology | Anti-Inflammatory Agents - blood | Antibodies, Monoclonal - blood | Antibodies, Monoclonal, Humanized | Anti-Inflammatory Agents - adverse effects | Antibodies, Monoclonal - administration & dosage | Long-Term Care - methods | Antibodies, Antinuclear - blood | Crohn Disease - blood | Crohn Disease - drug therapy | Injections, Subcutaneous | Adult | Anti-Inflammatory Agents - administration & dosage | Antibodies - blood | Female | Adalimumab | Drug Therapy, Combination | Cancer regression | Physiological aspects | Crohn's disease | Research | Drug therapy | Tumor necrosis factor-TNF | Psoriasis | Pharmaceutical industry | Bowel disease | Index Medicus | Abridged Index Medicus | tumour necrosis factor antagonists | randomised controlled trial | Inflammatory Bowel Disease | gastroenterology | adalimumab
Journal Article
Journal of affective disorders, ISSN 0165-0327, 2017, Volume 213, pp. 138 - 150
Psychiatry | Olanzapine | Ziprasidone | Mood stabilizers | Long-term | Lithium | Aripiprazole | Valproic acid | Valproate | Add-on | Adjunctive | Combination | Adjunct | Depressive | Risperidone | Manic | Quetiapine | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antipsychotic Agents - therapeutic use | Bipolar Disorder - drug therapy | Humans | Bipolar disorder | Antipsychotic drugs | Analysis | Social service | Index Medicus | MEDICINE | MEDICIN
Journal Article